CMPS · COMPASS Pathways plc · Held by Funds
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of CMPS by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 0.69% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.05% | 62,962 |
| Index ETFs | 0.65% | 895,715 |
| Active ETFs | 2.78% | 3,851,704 |
| Active funds | 0.61% | 840,782 |
| Unclassified | 0.02% | 21,455 |
| All registered funds | 4.10% | 5,672,618 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding CMPS
21 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | ARKG | 4,463,875 | $50,664,981 | 3.25% | Long | 2026-07-31 | |
| iShares Biotechnology ETF | IBB | 764,943 | $10,823,943 | 0.12% | Long | 2026-06-30 | |
| AdvisorShares Psychedelics ETF | PSIL | 359,647 | $5,089,005 | 11.45% | Long | 2026-06-30 | |
| Royce Smaller-Companies Growth Fund | — | 178,000 | $2,518,700 | 1.06% | Long | 2026-06-30 | |
| Simplify Propel Opportunities ETF | SURI | 114,281 | $1,617,076 | 2.09% | Long | 2026-06-30 | |
| ROYCE SMALL-CAP TRUST, INC. | RVT | 89,000 | $1,259,350 | 0.05% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | GWX | 81,279 | $1,150,098 | 0.13% | Long | 2026-06-30 | |
| AdvisorShares Dorsey Wright ADR ETF | AADR | 61,700 | $873,055 | 2.09% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 60,753 | $859,655 | 0.02% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 62,962 | $850,617 | 0.00% | Long | 2026-08-31 | |
| Dunham Small Cap Growth Fund | — | 62,514 | $709,534 | 0.89% | Long | 2026-07-31 | |
| ROBO Global Healthcare Technology and Innovation ETF | HTEC | 56,358 | $639,663 | 0.93% | Long | 2026-07-31 | |
| TIFF MULTI-ASSET FUND | — | 30,931 | $437,674 | 0.03% | Long | 2026-06-30 | |
| Old Westbury Small & Mid Cap Strategies Fund | OWSMX | 30,489 | $346,050 | 0.00% | Long | 2026-07-31 | |
| Virtus Biotech Clinical Trials Etf | BBC | 25,731 | $292,047 | 0.63% | Long | 2026-07-31 | |
| ActivePassive International Equity ETF | APIE | 18,739 | $253,164 | 0.02% | Long | 2026-08-31 | |
| Defiance Next Gen Altered Experience ETF | — | 18,700 | $202,334 | 4.79% | Long | 2022-06-30 | |
| PSYK ETF | — | 8,437 | $69,605 | 3.65% | Long | 2023-02-28 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 5,056 | $66,031 | 0.10% | Long | 2026-05-31 | |
| ProShares Ultra Nasdaq Biotechnology | BIB | 3,487 | $45,540 | 0.06% | Long | 2026-05-31 | |
| Eventide International ETF | ESIM | 2,020 | $22,927 | 0.13% | Long | 2026-07-31 |